Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories

Abstract Prevention of medical errors is a major goal of healthcare, though healthcare workers themselves have not yet fully accepted or implemented reliable models of system error, and neither has the public. While there is widespread perception that most medical errors arise from an inappropriate or delayed clinical management, the issue of laboratory errors is receiving a great deal of attention due to their impact on the quality and efficiency of laboratory performances and patient safety. Haemolytic specimens are a frequent occurrence in clinical laboratories, and prevalence can be as high as 3.3% of all of the routine samples, accounting for up to 40%–70% of all unsuitable specimens identified, nearly five times higher than other causes, such as insufficient, incorrect and clotted samples. This article focuses on this challenging issue, providing an overview on prevalence and leading causes of in vivo and in vitro haemolysis, and tentative guidelines on identification and management of haemolytic samples in clinical laboratories. This strategy includes continuous education of healthcare personnel, systematic detection/quantification of haemolysis in any sample, immediate clinicians warning on the probability of in vivo haemolysis, registration of non-conformity, completing of tests unaffected by haemolysis and request of a second specimen for those potentially affected. Clin Chem Lab Med 2008;46:764–72.

[1]  Howanitz Pj,et al.  Chemistry specimen acceptability: a College of American Pathologists Q-Probes study of 453 laboratories. , 1997 .

[2]  A. Lyon,et al.  Effect of hemolysis on cardiac troponin T determination by the Elecsys 2010 immunoanalyzer. , 2004, Clinical biochemistry.

[3]  O Sonntag,et al.  Haemolysis as an interference factor in clinical chemistry. , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[4]  J. Honour,et al.  Unusual results from immunoassays and the role of the clinical endocrinologist , 2006, Clinical endocrinology.

[5]  Haemolysis in neonatal blood samples: a survey of practice , 2007, Annals of clinical biochemistry.

[6]  Xavier Bossuyt,et al.  Laboratory medicine: challenges and opportunities. , 2007, Clinical chemistry.

[7]  P. J. Howanitz,et al.  Chemistry specimen acceptability: a College of American Pathologists Q-Probes study of 453 laboratories. , 1997, Archives of pathology & laboratory medicine.

[8]  R. Sodi,et al.  Pneumatic tube system induced haemolysis: assessing sample type susceptibility to haemolysis , 2004, Annals of clinical biochemistry.

[9]  J. Campbell,et al.  Interference of o-raffinose cross-linked hemoglobin with routine Hitachi 717 assays. , 1997, Clinical chemistry.

[10]  S. Chien,et al.  Collecting factors related to the haemolysis of blood specimens. , 2008, Journal of clinical nursing.

[11]  N. de Jonge,et al.  Automated processing of serum indices used for interference detection by the laboratory information system. , 2005, Clinical chemistry.

[12]  M. Scott,et al.  Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. , 1997, Clinical chemistry.

[13]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[14]  A. Sanna,et al.  Process and risk analysis to reduce errors in clinical laboratories , 2007, Clinical chemistry and laboratory medicine.

[15]  Andrea Mosca,et al.  Recommendations for detection and management of unsuitable samples in clinical laboratories , 2007, Clinical chemistry and laboratory medicine.

[16]  S. Kazmierczak,et al.  Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions. , 1998, Clinical chemistry.

[17]  K. Speroni,et al.  Factors affecting hemolysis rates in blood samples drawn from newly placed IV sites in the emergency department. , 2005, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[18]  Elevated troponin levels associated with hemolysis. , 2005, The American journal of the medical sciences.

[19]  Mario Plebani,et al.  Errors in laboratory medicine. , 2002, Clinical chemistry.

[20]  G. Lippi,et al.  Phlebotomy issues and quality improvement in results of laboratory testing. , 2006, Clinical Laboratory.

[21]  S. Devaraj,et al.  Validation of an immunoassay for measurement of plasma total homocysteine. , 1999, American journal of clinical pathology.

[22]  J. Sweeney,et al.  The effect of specimen hemolysis on coagulation test results. , 2006, American journal of clinical pathology.

[23]  P. Carraro Potassium report of hemolyzed serum samples , 2008, Clinical chemistry and laboratory medicine.

[24]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[25]  J. Sandars,et al.  The frequency and nature of medical error in primary care: understanding the diversity across studies. , 2003, Family practice.

[26]  J. Livesey,et al.  Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. , 2001, Clinical biochemistry.

[27]  M Plebani,et al.  Hemolyzed specimens: a reason for rejection or a clinical challenge? , 2000, Clinical chemistry.

[28]  D. Callas,et al.  In vitro effects of a novel hemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays. , 1997, Clinical chemistry.

[29]  R. Wenk Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. , 1998, Clinical chemistry.

[30]  M. Mussap,et al.  Coagulation and plasma fibronectin parameters in HELLP syndrome , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[31]  N. Blanckaert,et al.  Evaluation of interferences in rate and fixed-time nephelometric assays of specific serum proteins. , 1999, Clinical chemistry.

[32]  G. Lippi,et al.  Influence of hemolysis on routine clinical chemistry testing , 2006, Clinical chemistry and laboratory medicine.

[33]  G. Lippi,et al.  Interference of blood cell lysis on routine coagulation testing. , 2006, Archives of pathology & laboratory medicine.

[34]  G. Lippi Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens , 2008 .

[35]  A. Saenger,et al.  Evaluation of hemoglobin interference in capillary heel-stick samples collected for determination of neonatal bilirubin. , 2007, Clinical biochemistry.

[36]  J. Phillips,et al.  The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[37]  G. Steen,et al.  Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach , 2007, Clinical chemistry and laboratory medicine.

[38]  Giuseppe Lippi,et al.  Risk management in the preanalytical phase of laboratory testing , 2007, Clinical chemistry and laboratory medicine.

[39]  Gerard Steen,et al.  Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays , 2006, Clinical chemistry and laboratory medicine.

[40]  M. Gladwin,et al.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. , 2005, JAMA.

[41]  Guder Wg Haemolysis as an influence and interference factor in clinical chemistry. , 1986 .

[42]  D. Jay,et al.  Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. , 1993, Clinical chemistry.

[43]  R. Hawkins Variability in potassium/hemoglobin ratios for hemolysis correction. , 2002, Clinical chemistry.

[44]  M. Grant,et al.  The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. , 2003, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[45]  M. Plebani Errors in clinical laboratories or errors in laboratory medicine? , 2006, Clinical chemistry and laboratory medicine.

[46]  M. Tsuang,et al.  Shifting emphasis from pharmacogenomics to theragnostics , 2006, Nature Biotechnology.

[47]  C. Selby,et al.  Interference in Immunoassay , 1999, Annals of clinical biochemistry.

[48]  R. Hawkins Correction and reporting of potassium results in haemolysed samples , 2006, Annals of clinical biochemistry.

[49]  Mario Plebani,et al.  Errors in laboratory medicine and patient safety: the road ahead , 2007, Clinical chemistry and laboratory medicine.

[50]  Correction of Factitious Hyperkalemia in Hemolyzed Specimens , 2007 .

[51]  D Grafmeyer,et al.  The Influence of Bilirubin, Haemolysis and Turbidity on 20 Analytical Tests Performed on Automatic Analysers , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[52]  N. Yoshikawa,et al.  Hemolysis in Serum Samples Drawn by Emergency Department Personnel versus Laboratory Phlebotomists , 2002 .

[53]  A. Shenkin,et al.  Mechanism of interference by haemolysis in the cardiac troponin T immunoassay , 2006, Annals of clinical biochemistry.

[54]  Mario Plebani,et al.  Errors in a stat laboratory: types and frequencies 10 years later. , 2007, Clinical chemistry.

[55]  F. Reyers,et al.  The effect of hemolysis on plasma antithrombin activity as determined by a chromogenic method. , 2007, Veterinary clinical pathology.